2022 Ethics Patients Safety 
European Pharmaceutical Review
JUNE 29, 2022
How does that impact the safety of the biologics? Safety is key to the development of any medicine, but the safety considerations linked to bioproduction are more complex because biologics are more sophisticated medicines than small molecules. London: EMEA; 1997 [cited May 2022]. References. Step 5 Version [Internet].
Pharmaceutical Technology
DECEMBER 21, 2022
This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated. Major AI deals in 2022. However, in 2022, other major players have also stepped up. Here are some of the initiatives that have been in the news in 2022. UK sets out to set global AI standards.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
MAY 2, 2023
3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. However, access to these medicines is not close to meeting patient demand, creating inequalities in the health prospects of those diagnosed with cancer. 1,2 In the EU, an estimated 2.7
European Pharmaceutical Review
OCTOBER 27, 2023
Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained. The UK’s approach has been regarded as “consistently slow”, Mansfield wrote.
Nixon Gwilt Law
APRIL 22, 2024
The rule aims to regulate and enhance the transparency, effectiveness, and safety of predictive DSIs used in healthcare settings, ensuring that these technologies are developed and managed responsibly. Effective: Ensures that DSIs achieve their intended outcomes, improving clinical decision-making and patient care.
PM360
JUNE 26, 2023
In its 2022 edition, the Access to Medicine Foundation report 2 analyzed the access strategy of 180 products across the top 20 pharmaceutical companies, of which 102 are on the WHO essential medicine list. For instance, emerging market branding is an effective strategy that can benefit both patients and pharmaceutical companies.
pharmaphorum
OCTOBER 14, 2022
— Circular Digital Health (DiCE project) (@circular_health) October 13, 2022. Devices such as smart pill boxes, electronic blood collection devices, wearable monitors, and intelligent labels are increasingly being used to improve healthcare efficiency and conditions for patients, but present an “expanding e-waste challenge.”
Expert insights. Personalized for you.
85 
Let's personalize your content